Diabetes-Associated Fibrin Enrichment in Cerebral Thrombi and Its Procedural Implications for Mechanical Thrombectomy
4 affiliations
- 1Department of Neurology, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul 03181, Republic of Korea
- 2Department of Neurology, Severance Stroke Center, Severance Hospital, Yonsei University College of Medicine, Seoul 03722, Republic of Korea
- 3Integrative Research Center for Cerebrovascular and Cardiovascular Diseases, Yonsei University College of Medicine, Seoul 03722, Republic of Korea
- 4Division of Interventional Neuroradiology, Department of Radiology, Severance Stroke Center, Severance Hospital, Yonsei University College of Medicine, Seoul 03722, Republic of Korea
Abstract
Background/Objectives: Diabetes is associated with altered fibrin biology, but its relationship with fibrin content in cerebral thrombi and the procedural relevance of this relationship during mechanical thrombectomy remain unclear. We investigated the association between diabetes and fibrin content in thrombectomy-retrieved cerebral thrombi and whether diabetes-associated differences in fibrin content mediated procedural outcomes of mechanical thrombectomy. Methods: We retrospectively analyzed patients with acute ischemic stroke who underwent mechanical thrombectomy and had retrieved thrombi available for histological analysis. Red blood cell, platelet, and fibrin contents were quantified immunohistochemically. The association between diabetes and fibrin content was evaluated using multivariable linear regression, with complementary sensitivity analyses based on intravenous tissue-type plasminogen activator administration and atrial fibrillation status. Mediation analyses were performed to estimate the indirect effects of diabetes on procedural outcomes through diabetes-associated changes in fibrin content. Results: Among 312 patients, 98 (31.4%) had diabetes. Patients with diabetes had greater fibrin content than those without diabetes (median, 37.0% [interquartile range, 26.4–52.9] vs. 30.9% [17.7–45.0]; p = 0.004), whereas red blood cell and platelet contents did not differ significantly between the groups. Diabetes remained associated with greater fibrin content in the primary adjusted analysis (β = +6.68 percentage points; 95% confidence interval [CI], 2.19–11.18; p = 0.004), and the association persisted after additional conditioning on initial glucose and in sensitivity analyses. Among patients with diabetes, neither HbA1c nor initial glucose was associated with fibrin content. Mediation analyses did not identify a detectable indirect effect of diabetes through fibrin content on successful reperfusion, complete reperfusion, first-pass effect, number of passes, or the requirement for ≥3 passes. Conclusions: Diabetes was independently associated with greater fibrin content in cerebral thrombi retrieved during mechanical thrombectomy, supporting the presence of a diabetes-associated fibrin-enriched thrombus phenotype. However, no detectable indirect effect of diabetes-associated differences in fibrin content on the examined procedural outcomes of mechanical thrombectomy was identified. These findings suggest that although diabetes is associated with a distinct quantitative change in cerebral thrombus composition, a corresponding procedural consequence was not detectable in the present study.
Related
- Adjunctive Cerebrolysin therapy following mechanical thrombectomy for tandem right internal carotid artery and middle cerebral artery occlusion with residual post-procedural perfusion deficit: a case report
- Home Intravenous Heparin Therapy via a Central Venous Port for Recurrent Cancer-associated Stroke Requiring Repeat Mechanical Thrombectomy
- Thrombus Compositional Balance Is Associated with Complete Reperfusion After Mechanical Thrombectomy
- Mechanical thrombectomy for post-thrombotic venous obstruction is associated with venous wound healing
- Dual-phase CTA filling pattern is associated with reperfusion-related complications after mechanical thrombectomy in late-window anterior circulation stroke.
BibTeX
@article{baek2026diabetesassociated,
title = {{Diabetes-Associated Fibrin Enrichment in Cerebral Thrombi and Its Procedural Implications for Mechanical Thrombectomy}},
author = {Jang-Hyun Baek and Hyo Suk Nam and JoonNyung Heo and Il Kwon and Byung Moon Kim and Dong Joon Kim and Young Dae Kim},
journal = {Journal of Clinical Medicine},
year = {2026},
month = oct,
doi = {10.3390/jcm15208136},
url = {https://www.mdpi.com/2077-0383/15/20/8136},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Diabetes-Associated Fibrin Enrichment in Cerebral Thrombi and Its Procedural Implications for Mechanical Thrombectomy
AU - Jang-Hyun Baek
AU - Hyo Suk Nam
AU - JoonNyung Heo
AU - Il Kwon
AU - Byung Moon Kim
AU - Dong Joon Kim
AU - Young Dae Kim
PY - 2026
DA - 2026/10/01
JO - Journal of Clinical Medicine
DO - 10.3390/jcm15208136
UR - https://www.mdpi.com/2077-0383/15/20/8136
AB - Background/Objectives: Diabetes is associated with altered fibrin biology, but its relationship with fibrin content in cerebral thrombi and the procedural relevance of this relationship during mechanical thrombectomy remain unclear. We investigated the association between diabetes and fibrin content in thrombectomy-retrieved cerebral thrombi and whether diabetes-associated differences in fibrin content mediated procedural outcomes of mechanical thrombectomy. Methods: We retrospectively analyzed patients with acute ischemic stroke who underwent mechanical thrombectomy and had retrieved thrombi available for histological analysis. Red blood cell, platelet, and fibrin contents were quantified immunohistochemically. The association between diabetes and fibrin content was evaluated using multivariable linear regression, with complementary sensitivity analyses based on intravenous tissue-type plasminogen activator administration and atrial fibrillation status. Mediation analyses were performed to estimate the indirect effects of diabetes on procedural outcomes through diabetes-associated changes in fibrin content. Results: Among 312 patients, 98 (31.4%) had diabetes. Patients with diabetes had greater fibrin content than those without diabetes (median, 37.0% [interquartile range, 26.4–52.9] vs. 30.9% [17.7–45.0]; p = 0.004), whereas red blood cell and platelet contents did not differ significantly between the groups. Diabetes remained associated with greater fibrin content in the primary adjusted analysis (β = +6.68 percentage points; 95% confidence interval [CI], 2.19–11.18; p = 0.004), and the association persisted after additional conditioning on initial glucose and in sensitivity analyses. Among patients with diabetes, neither HbA1c nor initial glucose was associated with fibrin content. Mediation analyses did not identify a detectable indirect effect of diabetes through fibrin content on successful reperfusion, complete reperfusion, first-pass effect, number of passes, or the requirement for ≥3 passes. Conclusions: Diabetes was independently associated with greater fibrin content in cerebral thrombi retrieved during mechanical thrombectomy, supporting the presence of a diabetes-associated fibrin-enriched thrombus phenotype. However, no detectable indirect effect of diabetes-associated differences in fibrin content on the examined procedural outcomes of mechanical thrombectomy was identified. These findings suggest that although diabetes is associated with a distinct quantitative change in cerebral thrombus composition, a corresponding procedural consequence was not detectable in the present study.
SN - 2077-0383
ER -